ReflectionBio to Present at the World Orphan Drug Congress USA 2020




ReflectionBio to Present at the World Orphan Drug Congress USA 2020

(2020/3/23) Reflection Biotechnologies Limited (ReflectionBio), a patient-driven biotech company focused on developing gene therapy and other novel therapies for treating rare diseases, will present at the upcoming World Orphan Drug Congress USA 2020. ReflectionBio’s founder & CEO, rare disease patient, Richard Yang, will present at the conference. The presentation topic is “Preparing for gene therapy clinical trials with a “By Patients, For Patients” approach.”

The World Orphan Drug Congress USA 2020 will be held at Gaylord National Resort & Convention Center, National Harbor, Maryland, USA from August 24 to August 26, 2020.